17 research outputs found
Psychotropic Medication Exposure and Age at Onset of Bipolar Disorder in Offspring of Parents with Bipolar Disorder
Response to Methylphenidate in Children with Attention Deficit Hyperactivity Disorder and Manic Symptoms in the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder Titration Trial
Manic Symptoms Associated with Isotretinoin and Methylphenidate Combination: a Case Report
WOS: 000345108400010lsotretinoin (Roaccutane (TM)) is a systemic synthetic retinoid used to treat acne vulgaris and some other dermatological diseases. Isotretinoin is associated with several psychiatric side effects. This case report describes an 18-year-old female patient with Attention Deficit Hyperactivity Disorder, who developed manic symptoms during isotretinoin and methylphenidate (Concerta (TM)) combination treatment. She had no personal or family history of bipolar disorder. Although there are reports suggesting that both isotretinoin and methylphenidate may be separately associated with manic symptoms, to our knowledge, this is the first case report describing that manic symptoms might emerge as a result of the additive effect of combined isotretinoin and methylphenidate treatment